HAMP and metabolic dysfunction-associated steatohepatitis: Although levels of serum hepcidin are not suppressed in NAFLD/NASH, at least not in early stages of the disease, hepcidin eventually starts to drop in NAFLD with advanced fibrosis, similar to other liver diseases (Jamali et al. 2016).